Deliveries of Janssen vaccine to EU halted over concerns about thrombosis cases

The Dutch vaccination strategy has encountered another bump in the road. Rare cases of thrombosis may now also be linked to the Janssen vaccine. As a precautionary measure, the manufacturer has halted all deliveries of the vaccine to Europe. 

The Netherlands has ordered 11.3 million doses of the Janssen (also known as Johnson & Johnson) vaccine. The Janssen vaccine offers sufficient immunity from coronavirus after just one shot, meaning that the country hopes to vaccinate 11.3 million people using this vaccine.

Next Thursday, the country was set to begin distributing 80,000 doses of the vaccine to healthcare workers. Whether or not this will go ahead is uncertain.

Reports of thrombosis in the US

The decision follows reports of low platelet counts and rare cases of thrombosis in women between the age of 18 and 48 in the US. However, the number of cases so far appears to be lower than those reported after receiving the AstraZeneca vaccine.

So far, seven million people have received the Janssen vaccine. Out of these, there have been six cases of thrombosis, bringing the risk to less than one in a million. With the AstraZeneca vaccine, this risk is slightly higher, at about one in a hundred thousand.

AstraZeneca in the Netherlands

In the Netherlands, the distribution of AstraZeneca was briefly paused following similar reports. It was then decided that only people over the age of 60 would receive the vaccine as the EMA ruled the “benefits outweigh the risks.”

However, the Netherlands is already experiencing the damaging impact of the doubt over the use of AstraZeneca with 40% of over 60s in the Netherlands saying that they don’t want to receive the vaccine.

Cabinet awaits findings of the experts

The Dutch cabinet has no clear strategy yet concerning the continued distribution of the Janssen vaccine in the Netherlands.

Speaking at last night’s press conference, Minister for Health, Hugo De Jonge, briefly mentioned the vaccine. He said that he was unsure of whether the vaccine will continue to be used in the Netherlands and it must first be determined whether or not it’s safe.

The Dutch cabinet will now await the findings of research carried out by the European Medicines Agency (EMA) and the Medicines Evaluation Board (MEB).

According to the RIVM, vaccinations with the Janssen vaccine will continue next Thursday unless another decision is reached in the meantime.

What are your thoughts on the Dutch vaccination strategy? Let us know in the comments below! 

Feature Image: Janssen.com/Press Release

Sarah O'Leary 🇮🇪
Sarah O'Leary 🇮🇪
Before becoming the Senior Editor of DutchReview, Sarah was a fresh-faced international looking to learn more about the Netherlands. Since moving here in 2017, Sarah has added a BA in English and Philosophy (Hons.), an MA in Literature (Hons.), and over three years of writing experience at DutchReview to her skillset. When Sarah isn't acting as a safety threat to herself and others (cycling), you can find her trying to sound witty while writing about some of the stickier topics such as mortgages and Dutch law.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related posts

Latest posts

Is Simyo a good mobile provider for life in the Netherlands?

With affordable prepaid and SIM-only plans, eSIM functionality, and excellent customer service, Simyo is a solid choice for internationals looking to get connected in...

The king doesn’t have to pay income tax, new Dutch prime minister says

Remember last January, when the Dutch cabinet seemed really set on making the Royal Family pay income tax? Well, it's all in the past:...

The guide to relocating your pet to the Netherlands in 2024

Are you relocating your fluffy best friend with you to the Netherlands? Well, prepare for some good planning and a pile of paperwork. To...

It's happening

Upcoming events

The latest Dutch news.
In your inbox.